Publicaties WCN-studies: dr. A.F.M. Kuijper

• Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trialsLancet - Martens, dr. F.M.A.C. [inactief]; Kuijper, dr. A.F.M. - REDUCE-it; STRENGTH; PROMINENT - ASCVD; Diabetes mellitus March 2023
• Colchicine in Patients with Chronic Coronary DiseaseNew England Journal of Medicine - Abstract - Mosterd, dr. A.; Fiolet, dr. A. [inactief]; The, dr. S.H.K. [inactief]; Lenderink, dr. T.; Hoogslag, drs. P.A.M.; Jerzewski, dr. A. [inactief]; Nierop, drs. P.R.; Swart, drs. H.P.; Schaap, dr. J.; Kuijper, dr. A.F.M.; Hessen, dr. M.W.J. van; Dirksen, dr. M.T.; Alings, dr. A.M.W.; Schut, drs. A.; Cornel, prof. dr. J.H. - LoDoCo2 - ASCVD August 2020
• Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesN Engl J Med - Abstract - Kuijper, dr. A.F.M. - Improve-IT - ASCVD June 2015
• Long-term use of ticagrelor in patients with prior myocardial infarctionN Engl J Med - Abstract - Kuijper, dr. A.F.M.; Oude Ophuis, dr. mr. A.J.M. - PEGASUS TIMI54 - ASCVD May 2015
• Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trialJAMA - Abstract - Kuijper, dr. A.F.M. - SOLID TIMI52 - ASCVD September 2014
• Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)Circulation - Abstract - Kuijper, dr. A.F.M. - ROCKET-AF - Arrhythmia July 2014
• Darapladib for preventing ischemic events in stable coronary heart diseaseN Engl J Med - Abstract - Kuijper, dr. A.F.M. - Stability LPL II - ASCVD May 2014
• Effects of dalcetrapib in patients with a recent acute coronary syndromeN Engl J Med - Kuijper, dr. A.F.M. - Dal-OUTCOMES - ASCVD November 2012
• Prasugrel versus clopidogrel for acute coronary syndromes without revascularizationN Engl J Med - Abstract - Kuijper, dr. A.F.M. - Trilogy - ASCVD October 2012
• Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AFLancet Neurol - Abstract - Kuijper, dr. A.F.M. - ROCKET-AF - Arrhythmia April 2012
• Vorapaxar in the secondary prevention of atherothrombotic eventsN Engl J Med - Abstract - Kuijper, dr. A.F.M. - TIMI 50, TRA-2P - ASCVD April 2012
• Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trialDiabetologia - Abstract - Kuijper, dr. A.F.M. - TIDE - Diabetes mellitus January 2012
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med - Abstract - Kuijper, dr. A.F.M. - ROCKET-AF - Arrhythmia September 2011
• Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyLancet - Abstract - Kuijper, dr. A.F.M. - SHIFT - Heart failure September 2010
• Lenient versus strict rate control in patients with atrial fibrillationN Engl J Med - Abstract - Bosker, dr. H.A. [inactief]; Alings, dr. A.M.W.; Cornel, prof. dr. J.H.; Tukkie, dr. R.; Kuijper, dr. A.F.M.; Tuininga, dr. Y.S. - RACE II - Arrhythmia April 2010
• Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndromeAm Heart J - Abstract - Hof, prof. dr. A.W. J. van 't; Alings, dr. A.M.W.; Lok, dr. D.J.A.; Liem, dr. A.H.; Kragten, dr. J.A.; Bronzwaer, drs. P.N.A. [inactief]; Cornel, prof. dr. J.H.; Freericks, M.P.; Hamer, drs. B.J.B.; Hamraoui, drs. K.; Hoedemaker, drs. G. [inactief]; Kuijper, dr. A.F.M.; Linssen, dr. G.C.M.; Louwerenburg, drs. J.W. [inactief]; Nierop, drs. P.R.; Oomen, drs. A. [inactief]; Plomp, drs. J.; Pos, drs. L.; Eck, dr. J.W.M. van; Willems, dr. F.F. - Dal-OUTCOMES - ASCVD December 2009